Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93761271 | 9376127 | 1 | I | 2013 | 20130621 | 20130630 | 20130630 | PER | ES-TEVA-414670ISR | TEVA | 0.00 | F | Y | 0.00000 | 20131120 | PH | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93761271 | 9376127 | 1 | PS | Carboplatino Teva 10 mg/ml concentrado para solucion para perfusion | 1 | INTRAVENOUS | D | 12J (450 MG),12KA (450 MG),12K270E | 77269 | POWDER FOR SUSPENSION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93761271 | 9376127 | 1 | Ovarian cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93761271 | 9376127 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93761271 | 9376127 | Abdominal pain upper | |
| 93761271 | 9376127 | Anxiety | |
| 93761271 | 9376127 | Dyspnoea | |
| 93761271 | 9376127 | Erythema | |
| 93761271 | 9376127 | Nausea | |
| 93761271 | 9376127 | Palpitations | |
| 93761271 | 9376127 | Tremor | |
| 93761271 | 9376127 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93761271 | 9376127 | 1 | 2013 | 0 |